Aerpio Pharmaceuticals-Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates

Aadi Bioscience, Inc. (AADI) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of$ 0.67. This compares to loss of $0.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.45%. A quarter ago, it was expected that this company would post a loss of$ 0.73 per share when it actually produced a loss of $0.60, delivering a surprise of 17.81%.Over the last four quarters, the company has su ...